Trials / Completed
CompletedNCT01614002
A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer
Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for Treatment of Breast Cancer, NSCLC, Prostate Carcinoma, Adenocarcinoma of Stomach and Advanced Squamous Cell Carcinoma of Head/Neck Region.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 371 (actual)
- Sponsor
- Onkovis GmbH · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main purpose of this observational study with Docetaxel is to determine the number of treatment cycles and the quantity of Doce onkovis needed therefore under the special circumstance of ambulant chemotherapy. onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective. Secondary objectives are the evaluation of the safety and tolerability of Doce onkovis. To this purpose data regarding co medications and adverse events are also collected.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2012-06-07
- Last updated
- 2015-06-04
Locations
23 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01614002. Inclusion in this directory is not an endorsement.